TRxADE Health Inc (MEDS) Actualités

Form 1-A - Offering Statement [Regulation A]

Form 8-K - Current report

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.

TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS...

Form DEF 14C - Other definitive information statements

Form PRE 14C - Other preliminary information statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team

TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS...

Form 8-K - Current report

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million

Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination...

Form 8-K - Current report

TRxADE Health, Inc. Announces Special Cash Dividend

TAMPA, FL, July 09, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (Nasdaq: MEDS) (the “Company”), announced...

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale

TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced...

Form 8-K - Current report